Toca 511 and Toca FC in patients with gastrointestinal tumors in the Toca 6 study.

被引：0
|
作者：
Merchan, Jaime R.
Ostertag, Derek
Jolly, Douglas J.
Tejera, Dalissa
Gruber, Harry E.
Shorr, Jolene
机构：
[1] Univ Miami, Miami, FL USA
[2] Tocagen Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.TPS880
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS880
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Toca 6: A phase 1b study of Toca 511 and Toca FC in patients with advanced solid tumors or lymphoma.
    Merchan, Jaime R.
    Ahnert, Jordi Rodon
    Falchook, Gerald
    Ostertag, Derek
    Tejera, Dalissa
    Gruber, Harry E.
    Jolly, Douglas J.
    Shorr, Jolene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Immunomodulation in tumor and peripheral blood following Toca 511 & Toca FC treatment in patients with solid tumors
    Falchook, Gerald
    Rodon, Jordi
    Venkat, Shree
    Donahue, Arthur
    Horner, Peder
    Thomassen, Amber
    Accomando, William
    Rodriquez-Aguirre, Maria
    Bentley, Cornelia
    Hogan, Daniel
    Ostertag, Derek
    Yavrom, Sharon
    Khoeh, Thian
    Jolly, Douglas
    Gruber, Harry
    Shorr, Jolene
    Merchan, Jaime
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Immune modulation after Toca 511 and Toca FC treatment of colorectal cancer patients
    Falchook, Gerald Steven
    Ahnert, Jordi Rodon
    Venkat, Shree
    Donahue, Arthur
    Horner, Peder
    Thomassen, Amber
    Accomando, William
    Rodriguez-Aguirre, Maria
    Bentley, Cornelia
    Hogan, Daniel
    Ostertag, Derek
    Yavrom, Sharon
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Shorr, Jolene
    Merchan, Jaime R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] Prior Radiation in Subjects Who Were Treated With Toca 511 and Toca FC Across 3 Toca 511 Phase 1 Trials
    Cloughesy, T. F.
    Aghi, M.
    Bota, D.
    Chen, C.
    Elder, J. B.
    Kalkanis, S. N.
    Kaptain, G. J.
    Kesari, S.
    Landolfi, J.
    Mikkelsen, T.
    Portnow, J.
    Robbins, J. M.
    Ostertag, D.
    Chu, A.
    Huang, T.
    Vogelbaum, M. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E66 - E67
  • [5] TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN MEDULLOBLASTOMA
    Richardson, Angela M.
    Collins, Sara A.
    Inagaki, Akihito
    Armstrong, L.
    Roussel, Martine
    Jolly, Douglas
    Robbins, David J.
    Ayad, Nagi
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2017, 19 : 193 - 193
  • [6] Therapeutic Activity of Gene Therapy with Toca 511 & Toca FC for Esophageal Cancer
    Suzuki, Tomohiro
    Hiraoka, Kei
    Inoko, Kazuho
    Inagaki, Akihito
    Sasaki, Katsunori
    Kushiya, Hiroki
    Umemoto, Kazufumi
    Sato, Osamu
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Boyle, Nicholas A.
    Jolly, Douglas J.
    Gruber, Harry E.
    Kasahara, Noriyuki
    Hirano, Satoshi
    MOLECULAR THERAPY, 2019, 27 (04) : 132 - 133
  • [7] TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Cloughesy, Timothy
    Petrecca, Kevin
    Walbert, Tobias
    Butowski, Nicholas
    Salacz, Michael
    Perry, James
    Damek, Denise
    Bota, Daniela
    Bettegowda, Chetan
    Zhu, Jay-Jiguang
    Iwamoto, Fabio
    Placantonakis, Dimitris
    Martinez, Nina
    Elder, J. Bradley
    Kaptain, George
    Cachia, David
    Moshel, Yaron
    Brem, Steven
    Picconi, David
    Nam Tran
    Nam, Do-Hyun
    Park, Chul-Kee
    Landolfi, Joseph
    Tran, David
    Ramakrishna, Rohan
    Fink, Karen
    Heros, Deborah
    Zadeh, Gelareh
    Nicholas, Garth
    Mehta, Vivek
    Robins, H. Ian
    Chen, Clark
    Pitz, Marshall
    Heth, Jason
    Nagpal, Seema
    Pearlman, Michael
    Ahluwalia, Manmeet
    Mohile, Nimish
    Merrell, Ryan
    Schiff, David
    Thompson, Reid
    Davis, Raphael
    Macdonald, David
    Kheoh, Thian
    Kabbinavar, Fairooz
    Lossos, Alexander
    Vogelbaum, Michael
    NEURO-ONCOLOGY, 2019, 21 : 284 - 284
  • [8] A phase Ib study of Toca 511, a retroviral replicating vector, followed by Toca FC in patients with advanced cancer
    Merchan, Jaime
    Rodon, Jordi
    Falchook, Gerald
    Venkat, Shree
    Ostertag, Derek
    Tejera, Dalissa
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Shorr, Jolene S.
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Effects of Toca 511 and Toca FC on tumor microenvironment and peripheral blood populations in patients with advanced malignancies
    Merchan, Jaime
    Rodon, Jordi
    Ostertag, Derek
    Venkat, Shree
    Donahue, Arthur
    Horner, Peder
    Tijera, Dalissa
    Kheoh, Thian
    Jolly, Douglas J.
    Gruber, Harry E.
    Shorr, Jolene S.
    Falchook, Gerald S.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [10] Encouraging survival with Toca 511 and Toca FC compared to external lomustine control.
    Cloughesy, Timothy Francis
    Aghi, Manish K.
    Chen, Clark
    Elder, J. Bradley
    Kesari, Santosh
    Kalkanis, Steven N.
    Kaptain, George
    Landolfi, Joseph C.
    Mikkelsen, Tom
    Portnow, Jana
    Robbins, Joan M.
    Ostertag, Derek
    Das, Asha
    Chu, Alice
    Vogelbaum, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345